Publications

Review Article

Clinical translation of peptide-based vaccine trials: the HER-2/neu model

Cancer Vaccines

2001

Authors:

Disis ML, Knutson KL, McNeel DG, Davis D, and Schiffman K

Journal:

Critical Reviews in Immunology

Volume:

21(1-3)

Page:

263-73

Pubmed:

https://pubmed.ncbi.nlm.nih.gov/11642608/

Original Article

HER2/neu peptide-based vaccines, with GM-CSF as an adjuvant, in patients with advanced-stage HER2/neu-expressing cancers

Cancer Vaccines

2000

Authors:

Schffman K and Disis ML

Journal:

Clinical Lung Cancer

Volume:

2(1)

Page:

74-7

Pubmed:

https://pubmed.ncbi.nlm.nih.gov/14731345/

Original Article

Antibody immunity to prostate cancer associated antigens can be detected in the serum of patients with prostate cancer

Cancer Vaccines

2000

Authors:

McNeel DG, Nguyen LD, Storer BE, Vessella R, Lange PH, and Disis ML

Journal:

Journal of Urology

Volume:

164(5)

Page:

1825-9

Pubmed:

https://pubmed.ncbi.nlm.nih.gov/11025777/

Original Article

Dendritic cells lose ability to present protein antigen after stimulating antigen-specific T cell responses, despite upregulation of MHC class II expression

Tumor Microenvironment

2000

Authors:

Bernhard H, Huseby ES, Hand SL, Lohmann M, Batten WY, Disis ML, Gralow JR, Meyer zum Bruschenfelde KH, Ohlen C and Cheever MA

Journal:

Immunobiology

Volume:

201(5)

Page:

568-82

Pubmed:

https://pubmed.ncbi.nlm.nih.gov/10834314/

Original Article

Pre-existent immunity to the HER-2/neu oncogenic protein in patients with HER-2/neu overexpressing breast and ovarian cancer

Cancer Vaccines

2000

Authors:

Disis ML, Knutson KL, Schiffman K, Rinn K, McNeel DG

Journal:

Breast Cancer Research and Treatment

Volume:

62(3)

Page:

245-52

Pubmed:

https://pubmed.ncbi.nlm.nih.gov/11072789/

Original Article

Delayed-type hypersensitivity response is a predictor of peripheral blood T-cell immunity after HER-2/neu peptide immunization

Cancer Vaccines

2000

Authors:

Disis ML, Schiffman K, Gooley TA, McNeel DG, Rinn K and Knutson KL

Journal:

Clinical Cancer Research

Volume:

6(4)

Page:

1347-50

Pubmed:

https://pubmed.ncbi.nlm.nih.gov/10778962/

Original Article

Immunity to WT1 in the animal model and in patients with acute myeloid leukemia

Cancer Vaccines

2000

Authors:

Gaiger A, Reese V, Disis ML and Cheever MA

Journal:

Blood

Volume:

96(4)

Page:

1480-9

Pubmed:

https://pubmed.ncbi.nlm.nih.gov/10942395/

Review Article

Cancer vaccines for the treatment and prevention of non small-cell lung cancer

Cancer Vaccines

2000

Authors:

Disis ML, West HL, and Schiffman K

Journal:

Clincal Lung Cancer

Volume:

1(4)

Page:

294-301

Pubmed:

https://pubmed.ncbi.nlm.nih.gov/14733635/

Review Article

Tumor vaccines for the management of prostate cancer

Cancer Vaccines

2000

Authors:

McNeel DG and Disis ML

Journal:

Arch Immunol Ther Exp

Volume:

48(2)

Page:

85-93

Pubmed:

https://pubmed.ncbi.nlm.nih.gov/10807048/

Review Article

Immunotherapeutic approaches for the treatment of breast cancer

Cancer Vaccines

1999

Authors:

Knutson KL, Schiffman K, Rinn K, and Disis ML

Journal:

Journal of Mammary Gland Biology and Neoplasia

Volume:

4(4)

Page:

353-65

Pubmed:

https://pubmed.ncbi.nlm.nih.gov/10705919/